Frontiers in Clinical Drug Research-Diabetes and Obesity
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By BENTHAM SCIENCE PUBLISHERS

9781608058563

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Topical Drugs for Diabetic Complications Current and Future

Frontiers in Clinical Drug Research-Diabetes and Obesity ◽

10.2174/9781608058563114010008 ◽

2014 ◽

pp. 211-288

Author(s):

Ryuhei Sano ◽

Tomohiko Sasase

Keyword(s):

Diabetic Complications ◽

Topical Drugs

Download Full-text

Liraglutide: Present and Future

Frontiers in Clinical Drug Research-Diabetes and Obesity ◽

10.2174/9781608058563114010005 ◽

2014 ◽

pp. 67-120

Author(s):

Dan Mircea Cheţa ◽

Cristian Serafinceanu ◽

Cornelia Zetu

Download Full-text

MicroRNA, A Diligent Conjurer in the Exposition of Diabetes

Frontiers in Clinical Drug Research-Diabetes and Obesity ◽

10.2174/9781608058563114010006 ◽

2014 ◽

pp. 121-148

Author(s):

Puneetpal Singh

Download Full-text

List of Contributors

Frontiers in Clinical Drug Research-Diabetes and Obesity ◽

10.2174/9781608058563114010002 ◽

2014 ◽

pp. iv-v

Download Full-text

Angiotensin Blockers and Renoprotection in Diabetic Chronic Kidney Disease is a Failed Paradigm? - A Revisionist View of Renoprotection in Diabetic Chronic Kidney Disease and A Novel Classification Scheme for Renoprotective Agents

Frontiers in Clinical Drug Research-Diabetes and Obesity ◽

10.2174/9781608058563114010003 ◽

2014 ◽

pp. 3-32

Author(s):

Macaulay A.C. Onuigbo

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Classification Scheme

Download Full-text

Drugs and the Peroxisome Proliferator Activated Receptors

Frontiers in Clinical Drug Research-Diabetes and Obesity ◽

10.2174/9781608058563114010007 ◽

2014 ◽

pp. 149-210

Author(s):

Kevin Stuart ◽

Andrew Hartland ◽

Mithun Bhartia ◽

Sudarshan Ramachandran

Keyword(s):

Peroxisome Proliferator ◽

Peroxisome Proliferator Activated Receptors

Download Full-text

New Approach to Preventing and Treating Diabetes Mellitus: Focus on Advanced Glycation End Products (AGE)

Frontiers in Clinical Drug Research-Diabetes and Obesity ◽

10.2174/9781608058563114010004 ◽

2014 ◽

pp. 33-66

Author(s):

Emilia Liao ◽

Agustin Busta ◽

Ashutosh Pareek ◽

Leonid Poretsky

Keyword(s):

Diabetes Mellitus ◽

Advanced Glycation End Products ◽

Advanced Glycation ◽

New Approach ◽

Glycation End Products ◽

End Products

Download Full-text

Index

Frontiers in Clinical Drug Research-Diabetes and Obesity ◽

10.2174/9781608058563114010009 ◽

2014 ◽

pp. 289-309

Author(s):

Atta-ur-Rahman

Download Full-text

Preface

Frontiers in Clinical Drug Research-Diabetes and Obesity ◽

10.2174/9781608058563114010001 ◽

2014 ◽

pp. i-iii

Download Full-text

Frontiers in Clinical Drug Research-Diabetes and ObesityLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By BENTHAM SCIENCE PUBLISHERS

Topical Drugs for Diabetic Complications Current and Future

Liraglutide: Present and Future

MicroRNA, A Diligent Conjurer in the Exposition of Diabetes

List of Contributors

Angiotensin Blockers and Renoprotection in Diabetic Chronic Kidney Disease is a Failed Paradigm? - A Revisionist View of Renoprotection in Diabetic Chronic Kidney Disease and A Novel Classification Scheme for Renoprotective Agents

Drugs and the Peroxisome Proliferator Activated Receptors

New Approach to Preventing and Treating Diabetes Mellitus: Focus on Advanced Glycation End Products (AGE)

Index

Preface

Frontiers in Clinical Drug Research-Diabetes and Obesity
Latest Publications